BIGBEAR
PHARMACEUTICALS
Baricitinib blocks the JAK-STAT signaling pathway and inhibits the intracellular signal transduction of multiple inflammatory cytokines.
AuthenticGuaranteeFast DeliveryPrivacy Approval AnnouncementINDIANAPOLIS, June 1, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced that···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 71
Approval AnnouncementINDIANAPOLIS, May 11, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced that the U.S. Fo···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 70
Approval AnnouncementINDIANAPOLIS, June 13, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced that the U.S. F···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 71
Conference OverviewThe annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida. It brought together clin···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 71
Study OverviewTUESDAY, March 18, 2025 -- A study presented at the annual meeting of the American Academy of Dermatology (AAD, held March 7–11 in Orlan···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 71
Study OverviewTUESDAY, Sept. 23, 2025 — A new study presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vi···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 71
Study OverviewMONDAY, Sept. 29, 2025 -- Two-year follow-up data from a study presented at the annual meeting of the European Association for the Study···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 72
Copyright2024@ BIGBEAR All right reserved BIGBEAR
